Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Case Report: A Case of Renal Cell Carcinoma Unclassified With Medullary Phenotype Exhibiting a Favorable Response to Combined Immune Checkpoint Blockade.

Frontiers in immunology - 1 Jan 2022

Takeda Masashi, Kashima Soki, Fuchigami Yasushi, Yoshino Takayuki, Kataoka Tatsuki R, Yamasaki Toshinari, Kagamu Hiroshi, Kobayashi Takashi, Akamatsu Shusuke

Abstract excerpt

Renal cell carcinoma unclassified with medullary phenotype (RCCU-MP) is an extremely rare variant of kidney cancer with poor prognosis. Recently, immune checkpoint inhibitors (ICIs) have been the mainstay of treatment for advanced clear cell renal cell carcinoma (RCC). However, the efficacy of ICI in the treatment of RCCU-MP remains unclear. Here, we report about a 63-year-old Japanese man who was referred to our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immune Checkpoint Inhibitors

Share to Leukocytes, Mononuclear

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 35865543
DOI: 10.3389/fimmu.2022.934991
PMCID: PMC9294239

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Case Report: A Case of Renal Cell Carcinoma Unclassified With Medullary Phenotype Exhibiting a Favorable Response to Combined Immune Checkpoint Blockade.PMID 35865543Read ↗

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read ↗

Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapySemantic proximity Read ↗

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseasesSemantic proximity Read ↗

Tumor Mutational Burden and Survival in Papillary Renal Cell Carcinoma PatientsSemantic proximity Read ↗

Integrative clinical and molecular characterization of translocation renal cell carcinomaSemantic proximity Read ↗

Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.Semantic proximity Read ↗

Immune response and resistance of clear cell renal cell carcinoma patients following immune checkpoint blockadeSemantic proximity Read ↗

Complete Response To Tislelizumab In A Muscle-Invasive Urothelial Carcinoma After Surgery Associated With Tumor Mutational Burden High: A Case ReportSemantic proximity Read ↗

Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.Semantic proximity Read ↗

Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.Semantic proximity Read ↗

Renal cell carcinoma.Semantic proximity Read ↗

Papillary renal cell carcinoma: current progress and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.